Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prevention of tuberculosis]

B Dautzenberg1

  • 1Service de Pneumologie, Groupe hospitalier Pitié-Salpêtrière, Paris.

Revue De Pneumologie Clinique
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Primary and secondary chemoprevention strategies aim to prevent new tuberculosis (TB) infections and disease progression. BCG vaccination and targeted chemoprophylaxis are key interventions, especially for high-risk individuals and multidrug-resistant TB cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Deleterious effects of heated tobacco on respiratory symptoms and lung function].

Revue des maladies respiratoires·2024
Same author

Revue des maladies respiratoires actualites·2021
Same author

Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials.

Respiratory medicine and research·2021
Same author

Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

[Systematic analysis of the scientific literature on heated tobacco].

Revue des maladies respiratoires·2018
Same author

[Old and new tobacco products].

Revue de pneumologie clinique·2018
Same journal

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Revue de pneumologie clinique·2018
Same journal

[Medical journals publication: Let's change].

Revue de pneumologie clinique·2018
Same journal

[Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

Revue de pneumologie clinique·2018
Same journal

[Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

Revue de pneumologie clinique·2018
Same journal

[Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

Revue de pneumologie clinique·2018
Same journal

[COPD and smoking cessation: Patients' expectations and responses of health professionals].

Revue de pneumologie clinique·2018
See all related articles

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Context:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating robust prevention strategies.
  • Multidrug-resistant tuberculosis (MDR-TB) poses a particular threat, requiring intensified preventive measures.
  • Identifying and protecting vulnerable populations, including children and immunocompromised individuals, is crucial for TB control.

Purpose:

  • To outline primary prophylaxis strategies for preventing new tuberculosis infections.
  • To detail secondary chemoprevention methods for halting latent TB infection progression to active disease.
  • To discuss management modifications based on drug resistance patterns and patient susceptibility.

Summary:

  • Primary prophylaxis involves early diagnosis, treatment, and BCG vaccination to reduce TB dissemination and contamination risk.

Related Experiment Videos

  • Chemoprophylaxis, using isoniazid or alternative regimens for MDR-TB, is vital for both primary and secondary prevention.
  • Secondary prevention targets asymptomatic reactivation and susceptible individuals with TB sequelae, especially those with HIV or undergoing immunosuppressive therapy.

    • Impact:

    • Effective chemoprevention reduces TB incidence and disease progression, contributing to global TB elimination efforts.
    • Tailored prophylaxis strategies, considering drug resistance and host factors, optimize treatment outcomes and minimize transmission.
    • Enhanced understanding of prophylaxis protocols improves clinical management and public health interventions against tuberculosis.